Your browser doesn't support javascript.
loading
Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity.
Zhang, Yong-Jie; Guo, Lin; Gonzales, Patrick K; Gendron, Tania F; Wu, Yanwei; Jansen-West, Karen; O'Raw, Aliesha D; Pickles, Sarah R; Prudencio, Mercedes; Carlomagno, Yari; Gachechiladze, Mariam A; Ludwig, Connor; Tian, Ruilin; Chew, Jeannie; DeTure, Michael; Lin, Wen-Lang; Tong, Jimei; Daughrity, Lillian M; Yue, Mei; Song, Yuping; Andersen, Jonathan W; Castanedes-Casey, Monica; Kurti, Aishe; Datta, Abhishek; Antognetti, Giovanna; McCampbell, Alexander; Rademakers, Rosa; Oskarsson, Björn; Dickson, Dennis W; Kampmann, Martin; Ward, Michael E; Fryer, John D; Link, Christopher D; Shorter, James; Petrucelli, Leonard.
Afiliação
  • Zhang YJ; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Guo L; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • Gonzales PK; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Gendron TF; Department of Integrative Physiology, Institute for Behavioral Genetics, University of Colorado, Boulder, CO, USA.
  • Wu Y; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Jansen-West K; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • O'Raw AD; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Pickles SR; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Prudencio M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Carlomagno Y; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Gachechiladze MA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Ludwig C; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • Tian R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Chew J; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • DeTure M; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, and Chan Zuckerberg Biohub, San Francisco, CA, USA.
  • Lin WL; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, and Chan Zuckerberg Biohub, San Francisco, CA, USA.
  • Tong J; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Daughrity LM; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • Yue M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Song Y; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • Andersen JW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Castanedes-Casey M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Kurti A; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Datta A; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Antognetti G; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • McCampbell A; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Oskarsson B; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Dickson DW; Protein Chemistry, Biogen Idec, Cambridge, MA, USA.
  • Kampmann M; Protein Chemistry, Biogen Idec, Cambridge, MA, USA.
  • Ward ME; Neurology Research, Biogen Idec, Cambridge, MA, USA.
  • Fryer JD; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Link CD; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA.
  • Shorter J; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Petrucelli L; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Science ; 363(6428)2019 02 15.
Article em En | MEDLINE | ID: mdl-30765536
ABSTRACT
How hexanucleotide GGGGCC (G4C2) repeat expansions in C9orf72 cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is not understood. We developed a mouse model engineered to express poly(PR), a proline-arginine (PR) dipeptide repeat protein synthesized from expanded G4C2 repeats. The expression of green fluorescent protein-conjugated (PR)50 (a 50-repeat PR protein) throughout the mouse brain yielded progressive brain atrophy, neuron loss, loss of poly(PR)-positive cells, and gliosis, culminating in motor and memory impairments. We found that poly(PR) bound DNA, localized to heterochromatin, and caused heterochromatin protein 1α (HP1α) liquid-phase disruptions, decreases in HP1α expression, abnormal histone methylation, and nuclear lamina invaginations. These aberrations of histone methylation, lamins, and HP1α, which regulate heterochromatin structure and gene expression, were accompanied by repetitive element expression and double-stranded RNA accumulation. Thus, we uncovered mechanisms by which poly(PR) may contribute to the pathogenesis of C9orf72-associated FTD and ALS.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Cadeia Dupla / Heterocromatina / Dipeptídeos / Proteína C9orf72 / Esclerose Lateral Amiotrófica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Cadeia Dupla / Heterocromatina / Dipeptídeos / Proteína C9orf72 / Esclerose Lateral Amiotrófica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos